A new study has indicated that a drug initially used for the treatment of the skin disease psoriasis may also be useful in the treatment of Crohn’s disease. Psoriasis is characterized by inflamed, itchy patches of skin and is a lifelong disease. Crohn’s is also a lifelong disease, but is indicated by inflammation and damage within the digestive tract, making digestion difficult and often painful. The common attribute of both diseases, inflammation, is where the drug Stelera comes into play. While more trials are necessary before Stelara officially becomes a Crohn’s treatment, the hope for a new option for treating this disease is a ray of hope for those suffering from it.
Read the entire article here: Is a New Crohn’s Disease Treatment on the Horizon?
Powered by Qumana
